Wutah pendapatan triwulanan Exagen Inc. (XGN)

Simbol lan logo merek Exagen Inc. (XGN)

The competent management of Exagen Inc. (XGN) is striving for stable earnings by actively promoting insurance coverage for tests. The quarterly revenue growth index visualizes cash flow dynamics, where the latest parameter stands at 6.70. Proprietary AVISE developments create a robust defensive barrier in rheumatology, while centralized sample processing ensures efficient business scaling without excessive hiring.

XGN Wutah dodolan kuartal marang kuartal exagen.com (04.07.2022 - 20.11.2026)

Rincian metrik lan analitis perusahaan Exagen Inc. (XGN)

- rega saham lan target rega konsensus:
- data dhuwit lan arus kas:
Pambiji fundamental:Exagen Diagnostics (XGN)
Produk sing diprodhuksi Exagen Diagnostics

Exagen Inc. demonstrates stable demand for specialized diagnostics of autoimmune pathologies. The current level of quarterly revenue growth converts annual income dynamics into a daily series, revealing the hidden pace of business expansion. This metric neutralizes volatility caused by insurance payouts and the frequency of physician referrals. Analyzing this trajectory allows for the timely recognition of waning demand, preventing capital losses for the investor.

Analisis pesaing

A - Wutah pendapatan kuartal marang kuartal|Tingkat wutah dodolan sajrone kuartal Quest Diagnostics Incorporated DGX|ILMN (illumina.com) - Wutah dodolan triwulanan|Wutah dodolan triwulanan Cologuard|RVTY (Revvity Corp) - Wutah pendapatan triwulanan|Wutah pendapatan triwulanan Bio-Rad Laboratories Inc|Wutah dodolan triwulanan NNNN (Anbio Biotechnology)|SHC (Sotera Health Company) - Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal QuidelOrtho Inc. QDEL|Wutah pendapatan triwulanan OPKO Health Inc OPK|CareDx Inc - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan MRVI (Maravai)|FLGT: Wutah pendapatan triwulanan|LAB (Standard BioTools Inc.) - Wutah pendapatan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal Cytek Biosciences Inc|Tingkat wutah pendapatan sajrone kuartal OraSure OSUR|Wutah pendapatan kuartal marang kuartal MDxHealth, Inc. (MDXH)|Lucid Diagnostics, Inc - Wutah dodolan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal Prenetics PRE|Insight Molecular (IMDX) - Tingkat wutah pendapatan sajrone kuartal|Trinity Biotech Corp - Wutah pendapatan triwulanan|Tingkat wutah dodolan sajrone kuartal ProPhase PRPH|AIMD: Wutah pendapatan triwulanan|CODX - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal Heart Test Laboratories, Inc.|Wutah pendapatan kuartal marang kuartal BMRA|Wutah pendapatan triwulanan CDIO|Onconetix - Wutah dodolan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal viraxbiolabs.com VRAX|Tingkat wutah dodolan sajrone kuartal Bluejay (BJDX)|AWH: Wutah dodolan triwulanan|Tingkat wutah dodolan sajrone kuartal Accelerate Diagnostics, Inc. AXDX|Centogene (CNTG) - Wutah pendapatan kuartal marang kuartal|Dinamika pendapatan kuartal marang kuartal ENZ (Enzo)|Wutah dodolan kuartal marang kuartal Fresh2 (FRES)|Genetic Technologies (GENE) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan ME|Wutah pendapatan kuartal marang kuartal PMD (Psychemedics Corporation)